What Fred Said: Schering-Plough's Hassan On Life In Big Pharma
Executive Summary
Fred Hassan's days as chairman of Schering-Plough are numbered, and he hasn't indicated his next step once his company's merger with Merck closes, likely later this year. He remained cagey - giving only a few indirect clues about his preferences in an interview held Sept. 23 as part of Windhover's Pharmaceutical Strategic Alliances conference in New York City